Charles Schwab Investment Management Inc Tela Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$5.3 - $7.61 $15,900 - $22,830	-3,000 Reduced 6.53%	42,911 $243,000
Q3 2023 Nov 08, 2023	BUY	$7.85 - $10.68 $23,793 - $32,371	3,031 Added 7.07%	45,911 $367,000
Q2 2023 Aug 09, 2023	BUY	$9.23 - $11.23 $395,782 - $481,542	42,880 New	42,880 $434,000
Q2 2021 Aug 16, 2021	SELL	$11.7 - $16.11 $216,999 - $298,792	-18,547 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.64 - $16.86 $79,862 - $115,676	6,861 Added 58.71%	18,547 $307,000
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $90,566 - $264,220	11,686 New	11,686 $152,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $51.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.